Healthcare Pharmaceutical Biotech

Glidewell Expands Next-Day Crown Service to BruxZir(R) Esthetic

April 28, 2026 9:00 AM

The Next-Day service from Glidewell is expanding to include BruxZir® Esthetic. Now, this service delivers the leading esthetic monolithic zirconia restoration to dental offices in as little as 21 hours after scan submission. Next-Day BruxZir Esthetic gives dentists access to beautiful crowns and bridges ready to seat tomorrow. "Dentists across the U.S. now rely on our Next-Day BruxZir Full-Strength service, not just for emergency cases, but also...

Read more

LayerBio Announces FDA Acceptance of Investigational New Drug (IND) Application for OcuRing-K, a Sustained-Release Ketorolac Implant for Cataract Surgery Patients

April 28, 2026 8:50 AM

LayerBio, a clinical-stage biotechnology company developing sustained-release ophthalmic therapies, today announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for OcuRing-K™, an intraocular implant designed to deliver therapeutic levels of ketorolac directly within the eye following cataract surgery. OcuRing-K is a proprietary implant formulation engineered to provide sustained,...

Read more

MDaudit Launches "Revenue Integrity Redefined" Campaign to Help Healthcare Organizations Reclaim Financial Control

April 28, 2026 8:00 AM

Revenue risk no longer begins and ends with managing denials. It now touches every stage of the revenue cycle - from documentation, charge capture, and coding to billing and denials management - and healthcare organizations relying on reactive, manual, and siloed oversight approaches are paying the price. In an environment defined by financial pressure, heightened regulatory scrutiny, and increasingly AI-powered payer behavior, reactive...

Read more

Black Book Releases 2026 State of Digital Healthcare Technology in Accountable Care Organizations eBook

April 28, 2026 7:15 AM

Black Book Research today released its new industry eBook, The 2026 State of Digital Healthcare Technology in Accountable Care Organizations, examining how accountable care organizations are modernizing digital infrastructure as downside risk, quality measurement, payer interoperability, prior authorization automation, and care orchestration intensify across the ACO market. The report is available at no charge to healthcare industry stakeholders...

Read more

Independent Medical Practices Face Mounting Pressure as Medicare Reimbursement Strains Traditional Care Models

April 28, 2026 5:10 AM

Independent medical practices in markets such as Huntsville are entering a period of growing strain as Medicare reimbursement continues to challenge traditional care models, prompting providers to rethink how community-based healthcare can remain viable in the years ahead. Discovery Medical Center says the pressure is contributing to a widening divide between practices built primarily around reimbursement and those developing more diversified...

Read more

SphingoTec Introduces ELISA sphingotest(R) penKid(R) to Enable Broad Kidney Biomarker Testing for Research Applications

April 28, 2026 3:10 AM

SphingoTec GmbH announces the launch of the ELISA sphingotest® penKid®, a new assay designed to make testing of its proprietary biomarker broadly accessible to research laboratories and pharmaceutical partners. Providing ease-of-use and precision, the test facilitates large-scale investigations of human kidney function in both acute and broader clinical research contexts. Responding to growing research interest The launch follows increasing...

Read more

BioNxt Applies Advanced Drug Delivery Strategy and Psychedelic Compound Library to Emerging Therapeutics Market Amid Accelerating Global Momentum

April 28, 2026 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce that it is evaluating opportunities to apply its proprietary drug delivery technologies to the emerging field of psychedelic therapeutics in response to accelerating regulatory, clinical, and policy momentum globally. Recent developments in the United States, including...

Read more

iZafe Group Q1 Interim Report, January-March 2026

April 28, 2026 2:50 AM

iZafe Group (STO:IZAFE-B) - iZafe Group AB (publ.) presents today, April 28th, its report for the first quarter. Financial Performance in Summary The Group's total net sales for the quarter amounted to 2,419 (1,318) TSEK and consisted entirely of recurring license revenues, with no hardware sales during the period. Compared to the corresponding quarter of the previous year, the development reflects the Company's established business model...

Read more

Hemogenyx Pharmaceuticals PLC Announces Institutional Fundraise

April 28, 2026 2:00 AM

Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce that it has raised £3,000,000 from a small group of institutional investors to support the acceleration of its clinical development programmes. The fundraising was completed through a direct subscription for 374,532 new ordinary shares in the Company at a market bid price at closing of trading on April 27 of £8.01 per share. The net proceeds from the fundraising will be used...

Read more

Genflow Biosciences PLC Announces Expansion of Confidentiality Agreements

April 28, 2026 2:00 AM

Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or the "Company"), a biotechnology company focused on the development of gene therapies for age-related diseases announces the expansion of its engagement with participants in the global animal health sector. Following the positive preliminary interim results reported in an RNS on February 12, 2026 and the initial execution of confidentiality agreements, the Company has entered into...

Read more

Recovery Beach Reopens With New Executive Director After Renovation

April 27, 2026 6:35 PM

Recovery Beach, a premier detox and residential treatment facility near Anaheim, California, is reopening April 27th with a new Executive Director, improved clinical offerings, and a renovated facility. New ownership facilitated these defining moves, which are set to reinvigorate an already successful addiction recovery program. Dr. Kenyota Dokes, a former psychotherapist turned executive, is Recovery Beach's new Executive Director. Known for...

Read more

What The Fake Marijuana News Doesn’t Tell You About Rescheduling

April 27, 2026 2:45 PM

For years, headlines have promised that marijuana rescheduling would transform the cannabis industry overnight. Investors celebrated. Operators cheered. Commentators declared legalization had finally arrived. But here's the reality: Marijuana rescheduling is not legalization. And for companies that are not prepared for federal pharmaceutical regulation, Schedule III could become one of the most disruptive transitions the cannabis sector has ever...

Read more

The Power of Prevention: Dr. Charles Howenstine Explains Why Arresting Dental Disease Should Be the Industry Standard

April 27, 2026 2:20 PM

In modern dentistry, much of the focus has traditionally been placed on treatment after problems have already progressed. Fillings, crowns, and surgical procedures often take center stage in both patient expectations and clinical conversations. But for Charles Howenstine DDS, a dentist and practice owner in Stevensville, Michigan, the real opportunity lies earlier in the process. His philosophy is clear and consistent: the future of dentistry...

Read more

Christian Care Ministry (Medi-Share) Announces New Chief Administrative Officer Shawn Curtis

April 27, 2026 12:37 PM

Christian Care Ministry, which for more than 30 years has administered the nationally-recognized Medi-Share health care sharing ministry, today announced that Shawn Curtis will be joining the organization as Chief Administrative Officer. Curtis has more than 20 years' experience in bridging front-line realities with organizational strategy, most recently serving as an HR executive with Walgreens. The CCM Board of Directors believes Curtis'...

Read more

Dr. Rebecca Hulbert Leads Georgian Mall Family Dental with a People-First Approach

April 27, 2026 11:40 AM

In a healthcare industry often driven by volume and efficiency, Dr. Rebecca Hulbert has taken a different path. As the founder of Georgian Mall Family Dental, Dr. Hulbert has built a growing practice in Barrie, Ontario by focusing on people first-both patients and staff. Since opening the clinic in 2013, she has expanded the business three times within the same location, growing a strong team and a loyal patient base along the way. Her approach...

Read more

Black Book Research Announces Release of State of Digital Healthcare IT: Finland 2026

April 27, 2026 10:15 AM

Black Book Research today announced the availability of its new market intelligence report, State of Digital Healthcare IT: Finland 2026, a qualitative, buyer-ready analysis of EHR adoption, clinical products technology, patient access, interoperability, analytics, imaging, and AI in medicine and hospitals across one of Europe's most digitally mature and nationally coordinated healthcare environments. The report finds that Finland has moved well...

Read more

Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)

April 27, 2026 9:30 AM

XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV): The following resolutions were passed at the Annual General Meeting (the "AGM") of XVIVO Perfusion AB (publ) ("XVIVO Perfusion" or the "Company") held today on 27 April 2026 in Gothenburg, Sweden. Adoption of Income Statement and Balance Sheet for the Financial Year 2025 and Discharge from Liability The AGM resolved to adopt the income statement and the consolidated income statement for the...

Read more

Jaguar Health Granted Extension Until May 15, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule; Company Announces Reverse Stock Split

April 27, 2026 9:00 AM

Jaguar Health, Inc. (Nasdaq:JAGX) ("Jaguar" or the "Company") today announced that on April 24, 2026, the Company received formal notice that the Nasdaq Hearings Panel (the "Panel") has granted Jaguar an extension through May 15, 2026, to demonstrate compliance with the $1.00 bid price rule for continued listing on The Nasdaq Capital Market. To evidence compliance, the Company must report a closing bid price of at least $1.00 per share for a...

Read more

The Ridge RTC Releases First Clinical Outcomes Report Showing 62% Reduction in Depression Symptoms, Sustained Through One Year Post-Discharge

April 27, 2026 9:00 AM

The Ridge RTC today released its 2025 Clinical Outcomes Report, the program's first independently validated study of patient outcomes across its residential treatment network. The findings, prepared by Pacific Analytics under the direction of Principal Researcher Kyle Van Duser, Ph.D., represent one of the most comprehensive outcome datasets in teen (12-17) and emerging adult (18-20) residential behavioral health treatment, covering several...

Read more

Aetna Announces Progress on Industry Leading Efforts To Simplify Prior Authorization

April 27, 2026 9:00 AM

Originally published on CVS Health Company News Aetna®, a CVS Health® company (NYSE:CVS), is setting the pace for prior authorization reform, moving faster and further to simplify access to care for patients and providers. Aetna announced the company has already standardized 88% of its prior authorization volume, exceeding industry commitments, and continues to maintain the fewest medical services requiring prior authorization among national...

Read more